Opus Genetics price target raised to $16 by Chardan Capital
Chardan Capital raised its price target for Opus Genetics to $16.00 per share from $13.00, per TradingView News ratings actions compiled.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.